Biblio

Export 785 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is V  [Clear All Filters]
2016
A. M. Fernandez, Hervas, R., Dominguez-Fraile, M., Garrido, V. Navarro, Gomez-Gutierrez, P., Vega, M., Vitorica, J., Perez, J. J., and Aleman, I. Torres, Blockade of the Interaction of Calcineurin with FOXO in Astrocytes Protects Against Amyloid-β-Induced Neuronal Death., J Alzheimers Dis, vol. 52, no. 4, pp. 1471-8, 2016.
A. M. Fernandez, Hervas, R., Dominguez-Fraile, M., Garrido, V. Navarro, Gomez-Gutierrez, P., Vega, M., Vitorica, J., Perez, J. J., and Aleman, I. Torres, Blockade of the Interaction of Calcineurin with FOXO in Astrocytes Protects Against Amyloid-β-Induced Neuronal Death., J Alzheimers Dis, vol. 52, no. 4, pp. 1471-8, 2016.
Y. Vermeiren, Janssens, J., Aerts, T., Martin, J. - J., Sieben, A., Van Dam, D., and De Deyn, P. P., Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 3, pp. 1079-96, 2016.
Y. Vermeiren, Janssens, J., Aerts, T., Martin, J. - J., Sieben, A., Van Dam, D., and De Deyn, P. P., Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 3, pp. 1079-96, 2016.
S. L. Gardener, Sohrabi, H. R., Shen, K. - K., Rainey-Smith, S. R., Weinborn, M., Bates, K. A., Shah, T., Foster, J. K., Lenzo, N., Salvado, O., Laske, C., Laws, S. M., Taddei, K., Verdile, G., and Martins, R. N., Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults., J Alzheimers Dis, vol. 52, no. 2, pp. 661-72, 2016.
S. Akoudad, M Gurol, E., Fotiadis, P., Koudstaal, P. J., Hofman, A., M Ikram, A., Greenberg, S. M., and Vernooij, M. W., Cerebral Microbleeds and Cerebrovascular Reactivity in the General Population: The EDAN Study., J Alzheimers Dis, vol. 53, no. 2, pp. 497-503, 2016.
N. Wang, Allali, G., Kesavadas, C., Noone, M. L., Pradeep, V. G., Blumen, H. M., and Verghese, J., Cerebral Small Vessel Disease and Motoric Cognitive Risk Syndrome: Results from the Kerala-Einstein Study., J Alzheimers Dis, vol. 50, no. 3, pp. 699-707, 2016.
I. van Steenoven, Aarsland, D., Weintraub, D., Londos, E., Blanc, F., van der Flier, W. M., Teunissen, C. E., Mollenhauer, B., Fladby, T., Kramberger, M. G., Bonanni, L., and Lemstra, A. W., Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort., J Alzheimers Dis, vol. 54, no. 1, pp. 287-95, 2016.
I. van Steenoven, Aarsland, D., Weintraub, D., Londos, E., Blanc, F., van der Flier, W. M., Teunissen, C. E., Mollenhauer, B., Fladby, T., Kramberger, M. G., Bonanni, L., and Lemstra, A. W., Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort., J Alzheimers Dis, vol. 54, no. 1, pp. 287-95, 2016.
A. De Vos, Struyfs, H., Jacobs, D., Fransen, E., Klewansky, T., De Roeck, E., Robberecht, C., Van Broeckhoven, C., Duyckaerts, C., Engelborghs, S., and Vanmechelen, E., The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 4, pp. 1523-38, 2016.
A. De Vos, Struyfs, H., Jacobs, D., Fransen, E., Klewansky, T., De Roeck, E., Robberecht, C., Van Broeckhoven, C., Duyckaerts, C., Engelborghs, S., and Vanmechelen, E., The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 4, pp. 1523-38, 2016.
H. A. Eyre, Acevedo, B., Yang, H., Siddarth, P., Van Dyk, K., Ercoli, L., Leaver, A. M., St Cyr, N., Narr, K., Baune, B. T., Khalsa, D. S., and Lavretsky, H., Changes in Neural Connectivity and Memory Following a Yoga Intervention for Older Adults: A Pilot Study., J Alzheimers Dis, vol. 52, no. 2, pp. 673-84, 2016.
O. Godefroy, Bakchine, S., Verny, M., Delabrousse-Mayoux, J. - P., Roussel, M., and Pere, J. - J., Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders., J Alzheimers Dis, vol. 51, no. 3, pp. 815-25, 2016.
A. E. Villarreal, Grajales, S., O'Bryant, S. E., Edwards, M., López, L., Montalván, A., and Britton, G. B., Characterization of Alzheimer's Disease and Mild Cognitive Impairment in Older Adults in Panama., J Alzheimers Dis, vol. 54, no. 3, pp. 897-901, 2016.
V. Bonet-Costa, Herranz-Pérez, V., Blanco-Gandía, M. C., Mas-Bargues, C., Inglés, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Miñarro, J., Borras, C., Garcia-Verdugo, J. Manuel, and Viña, J., Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 701-11, 2016.
D. Bergeron, Beauregard, J. - M., Guimond, J., Fortin, M. - P., Houde, M., Poulin, S., Verret, L., Bouchard, R. W., and Laforce, R., Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes., J Alzheimers Dis, vol. 49, no. 3, pp. 695-705, 2016.
M. Reda Bensaïdane, Beauregard, J. - M., Poulin, S., Buteau, F. - A., Guimond, J., Bergeron, D., Verret, L., Fortin, M. - P., Houde, M., Bouchard, R. W., Soucy, J. - P., and Laforce, R., Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers., J Alzheimers Dis, vol. 52, no. 4, pp. 1251-62, 2016.
L. Xiong, Davidsdottir, S., Reijmer, Y. D., Shoamanesh, A., Roongpiboonsopit, D., Thanprasertsuk, S., Martinez-Ramirez, S., Charidimou, A., Ayres, A. M., Fotiadis, P., Gurol, E., Blacker, D. L., Greenberg, S. M., and Viswanathan, A., Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit., J Alzheimers Dis, vol. 52, no. 1, pp. 171-8, 2016.
O. C. Küster, Kösel, J., Spohn, S., Schurig, N., Tumani, H., von Arnim, C. A. F., and Uttner, I., Cognitive Reserve in Alzheimer's Dementia: Diagnostic Accuracy of a Testing-the-Limits Paradigm., J Alzheimers Dis, vol. 52, no. 2, pp. 519-28, 2016.
A. Wimo, Sjölund, B. - M., Sköldunger, A., Qiu, C., Klarin, I., Nordberg, G., and von Strauss, E., Cohort Effects in the Prevalence and Survival of People with Dementia in a Rural Area in Northern Sweden., J Alzheimers Dis, vol. 50, no. 2, pp. 387-96, 2016.
T. Van Langenhove, Leyton, C. E., Piguet, O., and Hodges, J. R., Comparing Longitudinal Behavior Changes in the Primary Progressive Aphasias., J Alzheimers Dis, vol. 53, no. 3, pp. 1033-42, 2016.
N. Lelental, Brandner, S., Kofanova, O., Blennow, K., Zetterberg, H., Andreasson, U., Engelborghs, S., Mroczko, B., Gabryelewicz, T., Teunissen, C., Mollenhauer, B., Parnetti, L., Chiasserini, D., Molinuevo, J. Luis, Perret-Liaudet, A., Verbeek, M. M., Andreasen, N., Brosseron, F., Bahl, J. M. C., Herukka, S. - K., Hausner, L., Frölich, L., Labonte, A., Poirier, J., Miller, A. - M., Zilka, N., Kovacech, B., Urbani, A., Suardi, S., Oliveira, C., Baldeiras, I., Dubois, B., Rot, U., Lehmann, S., Skinningsrud, A., Betsou, F., Wiltfang, J., Gkatzima, O., Winblad, B., Buchfelder, M., Kornhuber, J., and Lewczuk, P., Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics., J Alzheimers Dis, vol. 52, no. 1, pp. 51-64, 2016.
A. Maes, Anthonissen, R., Wambacq, S., Simons, K., and Verschaeve, L., The Cytome Assay as a Tool to Investigate the Possible Association Between Exposure to Extremely Low Frequency Magnetic Fields and an Increased Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 3, pp. 741-9, 2016.
J. Vallortigara, Whitfield, D., Quelch, W., Alghamdi, A., Howlett, D., Hortobágyi, T., Johnson, M., Attems, J., O'Brien, J. T., Thomas, A., Ballard, C. G., Aarsland, D., and Francis, P. T., Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia., J Alzheimers Dis, vol. 50, no. 1, pp. 101-10, 2016.
L. A. Johnson, Gamboa, A., Vintimilla, R., Edwards, M., Hall, J., Weiser, B., Yadav, M., Dickensheets, T., and O'Bryant, S. E., A Depressive Endophenotype for Predicting Cognitive Decline among Mexican American Adults and Elders., J Alzheimers Dis, vol. 54, no. 1, pp. 201-6, 2016.

Pages